Phase I/II clinical trials of dendritic cell-based immunotherapy in patients with the biochemical relapse of the prostate cancer.
Radek Spisek
No relevant relationships to disclose
Michal Podrazil
No relevant relationships to disclose
Marek Babjuk
No relevant relationships to disclose
Ladislav Jarolim
No relevant relationships to disclose
Jitka Fucikova
No relevant relationships to disclose
Anna Fialova
No relevant relationships to disclose
Ivo Minarik
No relevant relationships to disclose
Hana Hromadkova
No relevant relationships to disclose
Jirina Bartunkova
No relevant relationships to disclose